R. Seror a, X. Mariette b, S. Bowman c, G. Baron a, J. Gottenberg d, H. Boostma e, E. Theander f, A. Tzioufas g, C. Vitali h, P. Ravaud a
on behalf of the EULAR Sjögren’s Task Force
a Département d’épidémiologie, biostatistiques et recherche clinique, hôpital Bichat, Paris, France
b Service de rhumatologie, hôpital Bicêtre, Le Kremlin Bicêtre, France
c Rheumatology department, university hospital Birmingham, Birmingham, Royaume-Uni
d Service de rhumatologie, hôpitaux universitaires de Strasbourg, Strasbourg, France
e Rheumatology department, university medical center Groningen, Groningen, Pays-Bas
f Department of rheumatology, Malmö university hospital, Malmö, Suisse
g Department of pathophysiology, school of medicine, university of Athens, Athens, Grèce
h Department of internal medicine and section of rheumatology, “Villamarina” hospital, Piombino, Italie